New Lines of Attack in HIV Prevention
November 12, 2010
Clinical trials testing biomedical means to prevent HIV infection during sex are gaining momentum, experts say.
In the coming months, "we're going to see a cascade of results" from trials of oral pre-exposure prophylaxis, said Mitchell Warren, executive director of AVAC, an HIV prevention advocacy group. In them, people in high-risk groups take one or two of the antiretroviral drugs typically prescribed to those already infected. It is hoped the ARVs will protect participants from sexually acquired HIV. Regulatory approval might be quick for oral PREP, since ARVs taken orally are already approved.
New York Times
11.09.2010; Donald G. McNeil Jr.
Prevalence and Correlates of Heterosexual Anal Intercourse Among Clients Attending Public STD Clinics in Los Angeles County
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)